封面
市場調查報告書
商品編碼
2061350

人工椎間盤市場:市場機會、成長促進因素、產業趨勢分析及未來預測(2026-2035)

Artificial Disc Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球人工椎間盤市場預計到 2025 年將達到 7.486 億美元,年複合成長率為 4.5%,到 2035 年將達到 12 億美元。

人工椎間盤市場-IMG1

市場成長的促進因素包括椎間盤退化性疾病盛行率的上升、脊椎移植材料和器械工程技術的不斷進步,以及人們對微創脊椎手術日益成長的偏好。先進醫療保健系統保險覆蓋範圍的擴大也促進了患者獲得人工椎間盤置換療法的機會。由於人口老化、久坐的生活方式和肥胖率的上升,脊椎疾病負擔日益加重,顯著增加了對能夠維持長期活動能力的治療方法的需求。需要手術介入的患者群體不斷擴大,推動了醫療機構對先進脊椎移植的廣泛應用。此外,生物材料和器械設計的持續改進提高了植入物的耐用性、耐磨性和生物相容性,並增強了其模擬自然脊椎運動的能力,從而改善了臨床療效,並增強了外科醫生的信心。

市場範圍
開始年份 2025
預測期 2026-2035
初始市場規模 7.486億美元
預測金額 12億美元
複合年成長率 4.5%

預計到2025年,頸椎人工椎間盤市佔率將達到69.5%,2035年將達到8.378億美元,2035年前的複合年成長率(CAGR)為4.7%。由於其能夠有效減輕相鄰脊椎節段的負擔並保持頸部活動度,該細分市場在治療頸椎退化性疾病方面持續保持主導地位。頸椎人工椎間盤因其良好的臨床療效和相對簡單的手術操作而廣受外科醫生認可。現代生活方式導致的頸椎退化性疾病病例不斷增加,進一步推動了市場需求。主要醫療市場中可靠的臨床療效證據和監管部門的批准也促進了該產品的普及。

到2025年,金屬-聚合物(MOP)產品將佔據63.1%的市場。此產品類型應用廣泛,因為它將金屬結構與聚合物芯材結合,兼具強度和柔軟性。這種設計有助於模擬脊椎的自然運動,同時減少摩擦並提高機械性能。聚合物組件增強了減震性能和整體動態相容性,有助於改善患者的治療效果。此外,與其他設計相比,併發症率更低,因此臨床上接受度高,並在各種外科手術中廣泛應用。

預計到2025年,北美人工椎間盤市佔率將達到59.5%。該地區擁有高度發展且成熟的醫療保健體系,創新脊椎手術已廣泛應用。大量退化性椎間盤病變患者以及人們對保留行動治療方法日益成長的認知,持續推動市場需求。主要醫療設備製造商的進駐以及對研發的持續投入,進一步促進了產品的創新。此外,優惠的報銷政策和先進脊椎技術的早期法規核准,也加速了全部區域的市場滲透。

目錄

第1章:分析方法和範圍

第2章執行摘要

第3章業界考察

  • 產業生態系分析
  • 影響產業的因素
    • 促進因素
      • 椎間盤退化盛行率增加
      • 人們對微創脊椎手術的興趣日益濃厚
      • 人工椎間盤材料和設計方面的技術進步
      • 已開發國家保險覆蓋範圍的擴大
    • 產業潛在風險與挑戰
      • 人工全人工椎間盤置換術費用高
      • 醫療設備的嚴格法規核准
    • 市場機遇
      • 擴大生物材料與植入領域的研究與開發
      • 下一代運動保持裝置的研發
  • 成長潛力分析
  • 監理情勢
  • 技術展望
    • 最新科技趨勢
    • 新興技術
  • 未來市場趨勢
  • 波特五力分析
  • PESTEL 分析
  • 價格趨勢分析
  • 人工智慧和生成式人工智慧對市場的影響
  • 投資與資金籌措分析
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 公司市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 競爭定位矩陣
  • 主要公司的競爭分析
  • 主要趨勢
    • 企業合併(M&A)
    • 商業夥伴關係與合作
    • 新產品發布
    • 業務拓展計劃

第5章 市場估算與預測:依類型分類(2022-2035 年)

  • 頸椎人工椎間盤
  • 腰椎人工椎間盤

第6章 市場估算與預測:依材料分類(2022-2035 年)

  • MOM (Metal-on-metal)
  • MOP (Metal-on-polymer)
  • 其他類型的材料

第7章 市場估計與預測:依應用領域分類(2022-2035 年)

  • 脊椎創傷
  • 脊髓退化疾病

第8章 市場估算與預測:依最終用途分類(2022-2035 年)

  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他最終用戶

第9章 市場估計與預測:按地區分類(2022-2035 年)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE

第10章:公司簡介

  • AxioMed
  • Centinel Spine
  • Globus Medical
  • HIGHRIDGE MEDICAL
  • Medtronic
  • Neuro France Implants
  • Orthofix
  • SIGNUS Medizintechnik
  • Spineart
  • Spineway Group
  • Stryker
簡介目錄
Product Code: 1183

The Global Artificial Disc Market was valued at USD 748.6 million in 2025 and is estimated to grow at a CAGR of 4.5% to reach USD 1.2 billion by 2035.

Artificial Disc Market - IMG1

Market growth is driven by the rising prevalence of degenerative disc diseases, continuous advancements in spinal implant materials and device engineering, and increasing preference for minimally invasive spine procedures. Expanding reimbursement coverage in developed healthcare systems is also supporting wider patient access to artificial disc replacement therapies. The growing burden of spinal disorders, fueled by aging populations, sedentary behavior, and increasing obesity rates, is significantly increasing demand for long-term motion-preserving treatment options. The expanding patient base requiring surgical intervention is encouraging greater adoption of advanced spinal implants across healthcare facilities. In addition, ongoing improvements in biomaterials and device design are enhancing durability, wear resistance, and biocompatibility, while also improving replication of natural spinal movement, thereby strengthening clinical outcomes and surgeon confidence.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$748.6 Million
Forecast Value$1.2 Billion
CAGR4.5%

The cervical artificial disc segment held a 69.5% share in 2025 and is estimated to reach USD 837.8 million by 2035, growing at a CAGR of 4.7% during 2035. This segment continues to lead due to its effectiveness in treating degenerative conditions in the neck region while maintaining motion and reducing stress on adjacent spinal segments. It is widely preferred by surgeons because of its favorable clinical results and comparatively less complex surgical procedures. Rising cases of cervical spine degeneration linked to modern lifestyle patterns are further supporting demand. Strong clinical validation and regulatory approvals in major healthcare markets have also contributed to increasing adoption rates.

The metal-on-polymer segment held a 63.1% share in 2025. This product category is widely used due to its ability to combine strength and flexibility through a metallic structure paired with a polymer core. This design helps replicate natural spinal motion while reducing friction and improving mechanical performance. The polymer component enhances shock absorption and overall biomechanical compatibility, which contributes to improved patient outcomes. Its lower complication profile compared to alternative designs has also supported strong clinical acceptance and widespread usage across surgical settings.

North America Artificial Disc Market held a 59.5% share in 2025. The region represents a highly advanced and mature healthcare environment with strong adoption of innovative spinal procedures. A large patient population affected by degenerative disc conditions, along with increasing awareness of motion-preserving treatment alternatives, continues to drive demand. The presence of leading medical device manufacturers and sustained investment in research and development further support ongoing product innovation. In addition, favorable reimbursement frameworks and early regulatory approvals for advanced spinal technologies are accelerating market penetration across the region.

Key companies operating in the Global Artificial Disc Industry include Globus Medical, Medtronic, Stryker, Orthofix, Spineart, Centinel Spine, Spineway Group, AxioMed, HIGHRIDGE MEDICAL, Neuro France Implants, and SIGNUS Medizintechnik. Companies in the artificial disc market are focusing on continuous product innovation through the development of next-generation motion-preserving spinal implants with improved durability and biocompatibility. Many players are investing heavily in research and clinical trials to strengthen product efficacy and expand surgical indications. Strategic collaborations with hospitals, orthopedic specialists, and research institutions help accelerate product adoption and clinical validation. Firms are also expanding their geographic presence in emerging healthcare markets to tap into rising surgical demand. Advances in biomaterials, including improved polymer and metal combinations, are being prioritized to enhance implant performance. In addition, companies are strengthening surgeon training programs to improve procedural outcomes and adoption rates.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Type trends
    • 2.2.3 Material trends
    • 2.2.4 Application trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of degenerative disc diseases
      • 3.2.1.2 Rising preference for minimally invasive spine surgeries
      • 3.2.1.3 Technological advancements in artificial disc materials and designs
      • 3.2.1.4 Expansion of reimbursement coverage in developed regions
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of artificial disc replacement procedures
      • 3.2.2.2 Stringent regulatory approvals for medical devices
    • 3.2.3 Market opportunities
      • 3.2.3.1 Increasing research and development in biomaterials and implants
      • 3.2.3.2 Development of next-generation motion-preserving devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape (Driven by primary research)
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 MEA
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends (Driven by primary research)
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Pricing trend analysis (Driven by primary research)
  • 3.10 Impact of AI & generative AI on the market
  • 3.11 Investment & funding analysis
  • 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis (Driven by primary research)
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Cervical artificial disc
  • 5.3 Lumbar artificial disc

Chapter 6 Market Estimates and Forecast, By Material, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Metal-on-metal
  • 6.3 Metal-on-polymer
  • 6.4 Other material types

Chapter 7 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Spinal trauma
  • 7.3 Degenerative spine disease

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Specialty clinic
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 AxioMed
  • 10.2 Centinel Spine
  • 10.3 Globus Medical
  • 10.4 HIGHRIDGE MEDICAL
  • 10.5 Medtronic
  • 10.6 Neuro France Implants
  • 10.7 Orthofix
  • 10.8 SIGNUS Medizintechnik
  • 10.9 Spineart
  • 10.10 Spineway Group
  • 10.11 Stryker